Drug Profile
DS 8587
Alternative Names: DS-8587Latest Information Update: 27 May 2014
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Class Antibacterials; Fluoroquinolones
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 27 May 2014 Discontinued - Phase-I for Bacterial infections in Japan (unspecified route)
- 05 Oct 2012 Phase-I development is ongoing in Japan
- 12 Sep 2012 Antimicrobial data from in vitro studies in Bacterial infections presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2012) ,